XML 21 R78.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Business Segment Information - Schedule of Depreciation and Amortization by SBU Reporting Segment (Detail) (USD $) In Thousands, unless otherwise specified | 12 Months Ended
--- | ---
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011
Sales Information [Line Items] |  |  |
Depreciation and amortization | $ 22,659 | $ 20,580 | $ 23,017
BioStim [Member] |  |  |
Sales Information [Line Items] |  |  |
Depreciation and amortization | 1,946 | 1,584 | 2,033
Biologics [Member] |  |  |
Sales Information [Line Items] |  |  |
Depreciation and amortization | 628 | 543 | 415
Extremity Fixation [Member] |  |  |
Sales Information [Line Items] |  |  |
Depreciation and amortization | 7,195 | 5,196 | 5,148
Spine Fixation [Member] |  |  |
Sales Information [Line Items] |  |  |
Depreciation and amortization | 12,794 | 10,752 | 9,211
Operating Segments [Member] | Corporate [Member] |  |  |
Sales Information [Line Items] |  |  |
Depreciation and amortization | $ 96 | $ 70 | $ 53

X
- Details
Name: | ofix_SalesInformationLineItems
Namespace Prefix: | ofix_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration